Association of FOXO۱ Rs۱۷۵۹۲۲۳۶ Polymorphism and Tumor Size in Papillary Thyroid Carcinoma

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 135

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RBMB-11-2_004

تاریخ نمایه سازی: 21 مرداد 1401

Abstract:

Background: A group of transcription factors involved in several cellular processes like cell growth, proliferation, cell cycle, differentiation and apoptosis which are critical to the cell biology of cancer is Forkhead Box O (FOXO) family. FOXOs are known as putative tumor suppressors. FOXO۱ is a member of FOXO family which its abnormal expression or function has been indicated to promote cell proliferation and tumorigenesis. The probable effects of FOXO۱ rs۱۷۵۹۲۲۳۶ polymorphism on Papillary thyroid carcinoma (PTC) and its clinical findings were evaluated. Methods: In total, ۱۵۶ PTC patients and ۱۵۸ healthy subjects were participated in the study. Genotyping of FOXO۱ rs۱۷۵۹۲۲۳۶ polymorphism was carried out using RFLP-PCR method.  Results: There was no association between the FOXO۱ rs۱۷۵۹۲۲۳۶ polymorphism and PTC in codominant, recessive, dominant, overdominant, and log-additive models. The frequency of rs۱۷۵۹۲۲۳۶A allele was ۱۳% in PTC and ۱۷% in control group and were not statistically significant (p= ۰.۱۵). The analysis of the relationship between FOXO۱ rs۱۷۵۹۲۲۳۶ polymorphism and clinical specifications of papillary thyroid carcinoma demonstrated no significant relationship between rs۱۷۵۹۲۲۳۶ polymorphism and PTC in different ages (< ۴۰ and≥ ۴۰), gender (male/female), extrathyroidal expansion, N stage, vascular invasion and capsular invasion in PTC patients. There was a relationship between FOX۱ rs۱۷۵۹۲۲۳۶ polymorphism and a larger tumor size (≥ ۱ cm) only in log-additive model (OR= ۲.۹۶, ۹۵% CI= ۰.۸۸-۹.۹۸; p= ۰.۰۴). Conclusions: FOXO۱ rs۱۷۵۹۲۲۳۶ polymorphism was not associated with PTC; however, this variant was associated with a larger tumor size (≥ ۱ cm) only in log-additive model.

Authors

Shaghayegh Saljooghi

Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.

Zahra Heidari

Department of Internal Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.

Mohsen Saravani

Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran & Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.

Mahnaz Rezaei

Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran & Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.

Saeedeh Salimi

Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran & Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Seyed Abutorabi E, Irani S, Yaghmaie M, Ghaffari SH. Abemaciclib ...
  • Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. ...
  • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, ...
  • Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, ...
  • Liu Y, Su L, Xiao H. Review of factors related ...
  • Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. ...
  • Hornsveld M, Smits LM, Meerlo M, Van Amersfoort M, Koerkamp ...
  • Farhan M, Wang H, Gaur U, Little PJ, Xu J, ...
  • Link W, Fernandez‐Marcos PJ. FOXO transcription factors at the interface ...
  • Jiramongkol Y, Lam EW-F. FOXO transcription factor family in cancer ...
  • Zhao HH, Herrera RE, Coronado-Heinsohn E, Yang MC, Ludes-Meyers JH, ...
  • Li T, Wu X, Zhu X, Li J, Pan L, ...
  • Heidari Z, Mohammadpour‐Gharehbagh A, Eskandari M, Harati‐Sadegh M, Salimi S. ...
  • Maruei‐Milan R, Heidari Z, Salimi S. Role of MDM۲ ۳۰۹T> ...
  • Beretta GL, Corno C, Zaffaroni N, Perego P. Role of ...
  • Chae Y-C, Kim J-Y, Park JW, Kim K-B, Oh H, ...
  • Yang L, Liu L, Zhang X, Zhu Y, Li L, ...
  • Zhang L-Y, Chen Y, Jia J, Zhu X, He Y, ...
  • Dong X-Y, Chen C, Sun X, Guo P, Vessella RL, ...
  • Yang L, Hu HM, Zielinska-Kwiatkowska A, Chansky HA. FOXO۱ is ...
  • https://doi.org/۱۰.۱۰۱۶/S۰۰۰۶-۲۹۱X(۰۵)۸۰۱۲۱-۴Kojima T, Shimazui T, Horie R, Hinotsu S, Oikawa T, ...
  • Tan C, Liu S, Tan S, Zeng X, Yu H, ...
  • Yan H, Li Q, Wu J, Hu W, Jiang J, ...
  • Yang X, Wu X, Fang N, Liu X, Liu X, ...
  • Wang Y, Zhou L, Chen J, Li J, He L, ...
  • Campa D, Husing A, Dostal L, Stein A, Drogan D, ...
  • Zhao Y, Wei J, Hou X, Liu H, Guo F, ...
  • Li T, Wu X, Zhu X, Li J, Pan L, ...
  • نمایش کامل مراجع